Simplex Trading’s Xeris Biopharma Holdings XERS Stock Holding History

Simplex Trading’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-45,931	Closed	-$373K	–	10292
2025 Q3	$373K	Sell	45,931 -30,713	-40%	-$204K	﹤0.01%	4204
2025 Q2	$357K	Buy	+76,644	New	+$351K	﹤0.01%	3872
2022 Q3	–	Sell	-4,056	Closed	-$6.71K	–	11021
2022 Q2	$6K	Sell	4,056 -187,325	-98%	-$395K	﹤0.01%	8759
2022 Q1	$489K	Sell	191,381 -130,014	-40%	-$318K	﹤0.01%	3870
2021 Q4	$941K	Buy	321,395 +308,466	+2,386%	+$666K	﹤0.01%	2945
2021 Q3	$53K	Sell	12,929 -300	-2%	-$871	﹤0.01%	7455
2021 Q2	$53K	Buy	+13,229	New	+$50.5K	﹤0.01%	7584
2020 Q4	–	Sell	-5,526	Closed	-$27.6K	–	9189
2020 Q3	$32K	Buy	5,526 +5,053	+1,068%	+$20.2K	﹤0.01%	6022
2020 Q2	$1K	Buy	+473	New	+$1.65K	﹤0.01%	7424

Other funds holding XERS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Simplex Trading's XERS Position: Q4 2025 in Review

Simplex Trading sold out of Xeris Biopharma Holdings (XERS) in Q4 2025, closing a stake of 45,931 shares — an estimated $373K sold.

Simplex Trading first reported a position in XERS in Q2 2020 and held it in 9 quarters. The position peaked at $941K in Q4 2021. 225 funds tracked by Wall St. Rank hold XERS as of Q4 2025.

Simplex Trading reported no remaining Xeris Biopharma Holdings position as of Q4 2025 after selling out during the quarter.
Simplex Trading sold 45,931 Xeris Biopharma Holdings shares in Q4 2025, an estimated $373K.
Simplex Trading first reported a position in Xeris Biopharma Holdings in Q2 2020 and held it in 9 quarters.
Simplex Trading's Xeris Biopharma Holdings position peaked at $941K in Q4 2021.
225 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.